Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journal Bone Marrow Disease
Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents Dec 2015 Leuk Res. myelodysplastic syndromes (MDS)
Assessment of Human Antihuman Antibodies to Eculizumab After Long-Term Treatment in Patients With Paroxysmal Nocturnal Hemoglobinuria Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: A treatment versus no-treatment study Dec 2015 Am J Hematol paroxysmal nocturnal hemoglobinuria (PNH)
Intravenous infusion of allogeneic mesenchymal stromal cells in refractory or relapsed aplastic anemia Dec 2015 Cytotherapy aplastic anemia
Myelodysplastic syndromes: pathophysiology, clinical and biological features Dec 2015 Ann Biol Clin (Paris) myelodysplastic syndromes (MDS)
Effect of lenalidomide treatment on clonal architecture of myelodysplastic syndromes without 5q deletion Dec 2015 Blood myelodysplastic syndromes (MDS)
Primary Myelodysplastic Syndromes: The Mayo Clinic Experience With 1000 Patients Nov 2015 Mayo Clin Proc myelodysplastic syndromes (MDS)
Lenalidomide Treatment for Lower Risk Nondeletion 5q Myelodysplastic Syndromes Patients Yields Higher Response Rates When Used Before Azacitidine Nov 2015 Clin Lymphoma Myeloma Leuk myelodysplastic syndromes (MDS)
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes Oct 2015 Leukemia myelodysplastic syndromes (MDS)
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system Oct 2015 Leukemia myelodysplastic syndromes (MDS)